"NEW USE OF DOCETAXEL FOR TREATING HEPATOCELLULAR CARCINOMA"
Application IN/PCT/2002/00185/DEL published 2007-01-19, filed 2002-02-15
The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1uM. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament tor use in the treatment of hepatocellular carcinoma.
Applicant
1)AVENTIS PHARMA S.A.,
:20 AVENUE RAYMOND ARON, F-92160 ANTONY, FRANCE, France
Inventor
1)CHIN-WEN CHI 2)HENG-LIANG LIN, 3)TSUNG-YUN LIU 4)WING-YIU LUI, 5)GAR-YANG CHAU
International Info
Classification: A61K 31/00
Publication Number: A61K 31/00
Application Date: 2000-08-29
Priority Information
9920548.6 U.K. 1999-08-31